{"downloaded": true, "htmlmade": false, "full": {"id": "30254629", "source": "MED", "pmid": "30254629", "pmcid": "PMC6141688", "fullTextIdList": {"fullTextId": "PMC6141688"}, "doi": "10.3389/fimmu.2018.01968", "title": "Assessment of Neutrophil Chemotaxis Upon G-CSF Treatment of Healthy Stem Cell Donors and in Allogeneic Transplant Recipients.", "authorString": "Thunstr\u00f6m Salzer A, Niemiec MJ, Hosseinzadeh A, Stylianou M, \u00c5str\u00f6m F, R\u00f6hm M, Ahlm C, Wahlin A, Ermert D, Urban CF.", "authorList": {"author": [{"fullName": "Thunstr\u00f6m Salzer A", "firstName": "Anna", "lastName": "Thunstr\u00f6m Salzer", "initials": "A", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Radiation Sciences, University of Ume\u00e5, Ume\u00e5, Sweden."}, {"affiliation": "Department of Clinical Microbiology & Laboratory of Molecular Infection Medicine Sweden, Ume\u00e5 University, Ume\u00e5, Sweden."}]}}, {"fullName": "Niemiec MJ", "firstName": "Maria J", "lastName": "Niemiec", "initials": "MJ", "authorId": {"@type": "ORCID", "#text": "0000-0001-5667-6032"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Clinical Microbiology & Laboratory of Molecular Infection Medicine Sweden, Ume\u00e5 University, Ume\u00e5, Sweden."}}}, {"fullName": "Hosseinzadeh A", "firstName": "Ava", "lastName": "Hosseinzadeh", "initials": "A", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Clinical Microbiology & Laboratory of Molecular Infection Medicine Sweden, Ume\u00e5 University, Ume\u00e5, Sweden."}}}, {"fullName": "Stylianou M", "firstName": "Marios", "lastName": "Stylianou", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Clinical Microbiology & Laboratory of Molecular Infection Medicine Sweden, Ume\u00e5 University, Ume\u00e5, Sweden."}}}, {"fullName": "\u00c5str\u00f6m F", "firstName": "Fredrik", "lastName": "\u00c5str\u00f6m", "initials": "F", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Radiation Sciences, University of Ume\u00e5, Ume\u00e5, Sweden."}}}, {"fullName": "R\u00f6hm M", "firstName": "Marc", "lastName": "R\u00f6hm", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Clinical Microbiology & Laboratory of Molecular Infection Medicine Sweden, Ume\u00e5 University, Ume\u00e5, Sweden."}}}, {"fullName": "Ahlm C", "firstName": "Clas", "lastName": "Ahlm", "initials": "C", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Clinical Microbiology & Laboratory of Molecular Infection Medicine Sweden, Ume\u00e5 University, Ume\u00e5, Sweden."}}}, {"fullName": "Wahlin A", "firstName": "Anders", "lastName": "Wahlin", "initials": "A", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Radiation Sciences, University of Ume\u00e5, Ume\u00e5, Sweden."}}}, {"fullName": "Ermert D", "firstName": "David", "lastName": "Ermert", "initials": "D", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Clinical Microbiology & Laboratory of Molecular Infection Medicine Sweden, Ume\u00e5 University, Ume\u00e5, Sweden."}}}, {"fullName": "Urban CF", "firstName": "Constantin F", "lastName": "Urban", "initials": "CF", "authorId": {"@type": "ORCID", "#text": "0000-0003-1438-1134"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Clinical Microbiology & Laboratory of Molecular Infection Medicine Sweden, Ume\u00e5 University, Ume\u00e5, Sweden."}}}]}, "authorIdList": {"authorId": [{"@type": "ORCID", "#text": "0000-0001-5667-6032"}, {"@type": "ORCID", "#text": "0000-0003-1438-1134"}]}, "dataLinksTagsList": {"dataLinkstag": ["supporting_data", "altmetrics"]}, "journalInfo": {"volume": "9", "journalIssueId": "2647771", "dateOfPublication": "2018", "monthOfPublication": "0", "yearOfPublication": "2018", "printPublicationDate": "2018-01-01", "journal": {"title": "Frontiers in immunology", "ISOAbbreviation": "Front Immunol", "medlineAbbreviation": "Front Immunol", "NLMid": "101560960", "ISSN": "1664-3224", "ESSN": "1664-3224"}}, "pubYear": "2018", "pageInfo": "1968", "abstractText": "Neutrophils are crucial for the human innate immunity and constitute the majority of leukocytes in circulation. Thus, blood neutrophil counts serve as a measure for the immune system's functionality. Hematological patients often have low neutrophil counts due to disease or chemotherapy. To increase neutrophil counts and thereby preventing infections in high-risk patients, recombinant G-CSF is widely used as adjunct therapy to stimulate the maturation of neutrophils. In addition, G-CSF is utilized to recruit stem cells (SCs) into the peripheral blood of SC donors. Still, the actual functionality of neutrophils resulting from G-CSF treatment remains insufficiently understood. We tested the <i>ex vivo</i> functionality of neutrophils isolated from blood of G-CSF-treated healthy SC donors. We quantified chemotaxis, oxidative burst, and phagocytosis before and after treatment and detected significantly reduced chemotactic activity upon G-CSF treatment. Similarly, <i>in vitro</i> treatment of previously untreated neutrophils with G-CSF led to reduced chemotactic activity. In addition, we revealed that this effect persists in the allogeneic SC recipients up to 4 weeks after neutrophil engraftment. Our data indicates that neutrophil quantity, as a sole measure of immunocompetence in high-risk patients should be considered cautiously as neutrophil functionality might be affected by the primary treatment.", "affiliation": "Department of Radiation Sciences, University of Ume\u00e5, Ume\u00e5, Sweden.", "publicationStatus": "epublish", "language": "eng", "pubModel": "Electronic-eCollection", "pubTypeList": {"pubType": ["Clinical Trial", "Research Support, Non-U.S. Gov't", "research-article", "Journal Article"]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Neutrophils", "meshQualifierList": {"meshQualifier": {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Hematopoietic Stem Cells", "meshQualifierList": {"meshQualifier": {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "N", "descriptorName": "Filgrastim", "meshQualifierList": {"meshQualifier": {"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "Y", "descriptorName": "Hematopoietic Stem Cell Transplantation"}, {"majorTopic_YN": "N", "descriptorName": "Chemotaxis", "meshQualifierList": {"meshQualifier": {"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Respiratory Burst", "meshQualifierList": {"meshQualifier": {"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Phagocytosis", "meshQualifierList": {"meshQualifier": {"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Adult"}, {"majorTopic_YN": "N", "descriptorName": "Middle Aged"}, {"majorTopic_YN": "Y", "descriptorName": "Tissue Donors"}, {"majorTopic_YN": "N", "descriptorName": "Female"}, {"majorTopic_YN": "N", "descriptorName": "Male"}]}, "keywordList": {"keyword": ["Chemotaxis", "Granulocyte colony stimulating factor (G-CSF)", "neutrophil", "Allogeneic Transplant", "Hematopoietic Stem Cell Donor"]}, "chemicalList": {"chemical": {"name": "Filgrastim", "registryNumber": "PVI5M0M1GW"}}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.3389/fimmu.2018.01968"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6141688"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6141688?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "Y", "citedByCount": "2", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCompletion": "2019-09-25", "dateOfCreation": "2018-09-27", "firstIndexDate": "2018-09-26", "fullTextReceivedDate": "2020-07-11", "dateOfRevision": "2019-09-25", "electronicPublicationDate": "2018-09-11", "firstPublicationDate": "2018-09-11"}, "htmllinks": "https://europepmc.org/articles/PMC6141688", "abstract": "Neutrophils are crucial for the human innate immunity and constitute the majority of leukocytes in circulation. Thus, blood neutrophil counts serve as a measure for the immune system's functionality. Hematological patients often have low neutrophil counts due to disease or chemotherapy. To increase neutrophil counts and thereby preventing infections in high-risk patients, recombinant G-CSF is widely used as adjunct therapy to stimulate the maturation of neutrophils. In addition, G-CSF is utilized to recruit stem cells (SCs) into the peripheral blood of SC donors. Still, the actual functionality of neutrophils resulting from G-CSF treatment remains insufficiently understood. We tested the <i>ex vivo</i> functionality of neutrophils isolated from blood of G-CSF-treated healthy SC donors. We quantified chemotaxis, oxidative burst, and phagocytosis before and after treatment and detected significantly reduced chemotactic activity upon G-CSF treatment. Similarly, <i>in vitro</i> treatment of previously untreated neutrophils with G-CSF led to reduced chemotactic activity. In addition, we revealed that this effect persists in the allogeneic SC recipients up to 4 weeks after neutrophil engraftment. Our data indicates that neutrophil quantity, as a sole measure of immunocompetence in high-risk patients should be considered cautiously as neutrophil functionality might be affected by the primary treatment.", "Keywords": ["Chemotaxis", "Granulocyte colony stimulating factor (G-CSF)", "neutrophil", "Allogeneic Transplant", "Hematopoietic Stem Cell Donor"], "pdflinks": "https://europepmc.org/articles/PMC6141688?pdf=render", "journaltitle": "Frontiers in immunology", "authorinfo": ["Thunstr\u00f6m Salzer A", "Niemiec MJ", "Hosseinzadeh A", "Stylianou M", "\u00c5str\u00f6m F", "R\u00f6hm M", "Ahlm C", "Wahlin A", "Ermert D", "Urban CF"], "title": "Assessment of Neutrophil Chemotaxis Upon G-CSF Treatment of Healthy Stem Cell Donors and in Allogeneic Transplant Recipients."}